{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:34:18Z","timestamp":1793352858417,"version":"4.5.0"},"reference-count":33,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"unspecified","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["1D43TW011544."],"award-info":[{"award-number":["1D43TW011544."]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Glob Health"],"accepted":{"date-parts":[[2025,7,1]]},"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Tuberculosis (TB) remains a leading cause of morbidity and mortality in Nigeria, particularly among people living with HIV (PLWH), who face significantly higher risks of developing active TB. Conventional diagnostic methods such as sputum smear microscopy and chest radiography often fail to detect TB accurately in this population due to smear-negative presentations and atypical radiographic findings. Recent diagnostic innovations, including the Xpert MTB\/RIF Ultra, TB lipoarabinomannan (TB-LAM) and TB loop-mediated isothermal amplification (TB-LAMP) tests, offer improved sensitivity and specificity, but their cost-effectiveness in resource-limited settings remains unclear.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In this economic evaluation, we combined a decision tree with cost-effectiveness analysis to compare three TB diagnostic algorithms tailored for PLWH in Nigeria: (1) Xpert MTB\/RIF Ultra following chest radiography (chest X-ray; CXR), (2) TB-LAM following CXR and (3) TB-LAMP following CXR. Data on test accuracy, costs and TB prevalence were obtained from systematic reviews and meta-analyses, with costs adjusted for inflation and local purchasing power. We estimated the incremental cost-effectiveness ratios (ICERs) for the three diagnostic approaches. Sensitivity analyses were conducted to assess the robustness of results across varying input parameters.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>TB\/LAM was found to be the most cost-effective option at a cost of US$17 per TB case detected when compared with US$20 and US$22 per TB case detected for the baseline strategy of Xpert MTB\/RIF Ultra and TB-LAMP, respectively. These ICERs are consistent with willingness-to-pay thresholds set at three times Nigeria\u2019s gross domestic product (GDP) and remained robust over a wide range of costs and epidemiological parameter inputs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Among PLWH in Nigeria, the TB-LAM algorithm represents the most cost-effective diagnostic strategy. However, the Xpert MTB\/RIF Ultra may provide additional value in settings with sufficient infrastructure and funding. This study underscores the need for tailored diagnostic approaches that balance accuracy, scalability and affordability to enhance TB detection and management in vulnerable populations.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjgh-2025-019270","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T18:20:15Z","timestamp":1754418015000},"page":"e019270","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Cost-effectiveness of different tuberculosis diagnostic approaches in Nigeria based on decision analytical modelling"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8378-380X","authenticated-orcid":false,"given":"Hafsat U","family":"Ibrahim","sequence":"first","affiliation":[{"name":"Paediatrics, Aminu Kano Teaching Hospital, Kano, Nigeria"},{"name":"Paediatrics, Bayero University, Kano, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6365-7091","authenticated-orcid":false,"given":"Rayyan M","family":"Garba","sequence":"additional","affiliation":[{"name":"Community Medicine, Aminu Kano Teaching Hospital, Kano, Nigeria"},{"name":"Community Medicine, Bayero University, Kano, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jameel I","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Surgery, Aminu Kano Teaching Hospital, Kano, Nigeria"},{"name":"Surgery, Bayero University, Kano, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kabiru","family":"Abdulsalam","sequence":"additional","affiliation":[{"name":"Chemical Pathology and immunology, Aminu Kano Teaching Hospital, Kano, Nigeria"},{"name":"Bayero University, Kano, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasir N","family":"Jibril","sequence":"additional","affiliation":[{"name":"Otorhinolaryngology, Aminu Kano Teaching Hospital, Kano, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal S","family":"Dankishiya","sequence":"additional","affiliation":[{"name":"Africa Center of Excellence for Population Health and Policy, Bayero University, Kano, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullahi","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Medicine, Aminu Kano Teaching Hospital, Kano, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim U","family":"Garzali","sequence":"additional","affiliation":[{"name":"Surgery, Aminu Kano Teaching Hospital, Kano, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha A","family":"Galadanci","sequence":"additional","affiliation":[{"name":"Haematology and Blood transfusion, Aminu Kano Teaching Hospital, Kano, Nigeria"},{"name":"Haematology and Blood transfusion, Bayero University, Kano, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullahi K","family":"Suleiman","sequence":"additional","affiliation":[{"name":"Aminu Kano Teaching Hospital, Kano, Kano, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulgafar L","family":"Olawumi","sequence":"additional","affiliation":[{"name":"Family Medicine, Aminu Kano Teaching Hospital, Kano, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umar F","family":"Abdullahi","sequence":"additional","affiliation":[{"name":"Medicine, Aminu Kano Teaching Hospital, Kano, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima M","family":"Mahmud","sequence":"additional","affiliation":[{"name":"Africa Center of Excellence for Population Health and Policy, Bayero University, Kano, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina A","family":"Umar","sequence":"additional","affiliation":[{"name":"Community Medicine, Aminu Kano Teaching Hospital, Kano, Nigeria"},{"name":"Cmmunity Medicine, Bayero University, Kano, Kano, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olive","family":"Asafu- Adjaye","sequence":"additional","affiliation":[{"name":"Greater Accra Regional Hospital, Accra, Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukman F","family":"Owolabi","sequence":"additional","affiliation":[{"name":"Bayero University, Kano, Nigeria"},{"name":"Medicine, Aminu Kano Teaching Hospital, Kano, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baba M","family":"Musa","sequence":"additional","affiliation":[{"name":"Africa Center of Excellence for Population Health and Policy, Bayero University, Kano, Nigeria"},{"name":"Aminu Kano Teaching Hospital, Kano, Kano, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muktar H","family":"Aliyu","sequence":"additional","affiliation":[{"name":"Vanderbilt Institute for Global Health, Vanderbilt University Medical Center, Nashville, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"key":"2025080511200701000_10.8.e019270.1","unstructured":"World Health Organization . Global tuberculosis report 2020. Geneva WHO; 2020."},{"key":"2025080511200701000_10.8.e019270.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907847"},{"key":"2025080511200701000_10.8.e019270.3","first-page":"104","article-title":"Accuracy of chest radiography for the diagnosis of tuberculosis: a systematic review","volume":"70","author":"Horne","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"2025080511200701000_10.8.e019270.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31267-4"},{"key":"2025080511200701000_10.8.e019270.5","unstructured":"World Health Organization . Lateral Flow urine lipoarabinomannan assay (lf-lam) for the diagnosis of active tuberculosis in people living with hiv: policy update. Geneva: WHO, 2019."},{"key":"2025080511200701000_10.8.e019270.6","unstructured":"World Health Organization . The use of loop-mediated isothermal amplification (TB-LAMP) for the diagnosis of pulmonary tuberculosis: policy guidance. Geneva: WHO, 2016."},{"key":"2025080511200701000_10.8.e019270.7","unstructured":"World Health Organization . Guidelines for treatment of drug-susceptible tuberculosis and patient care. Geneva: WHO, 2017."},{"key":"2025080511200701000_10.8.e019270.8","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30691-6"},{"key":"2025080511200701000_10.8.e019270.9","unstructured":"National Tuberculosis, Leprosy and Buruli Ulcer Control Programme (NTBLCP) . Annual TB report 2020. Federal Ministry of Health Nigeria; 2020."},{"key":"2025080511200701000_10.8.e019270.10","doi-asserted-by":"crossref","DOI":"10.2196\/40311","article-title":"Identifying Hot Spots of Tuberculosis in Nigeria Using an Early Warning Outbreak Recognition System: Retrospective Analysis of Implications for Active Case Finding Interventions","volume":"9","author":"Ogbudebe","year":"2023","journal-title":"JMIR Public Health Surveill"},{"key":"2025080511200701000_10.8.e019270.11","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-020-05626-3","article-title":"General and tuberculosis-specific service readiness in two states in Nigeria","volume":"20","author":"Oluwasanu","year":"2020","journal-title":"BMC Health Serv Res"},{"key":"2025080511200701000_10.8.e019270.12","unstructured":"AMUA software version 3.0. user manual and specifications. 2024."},{"key":"2025080511200701000_10.8.e019270.13","unstructured":"Central Bank of Nigeria . Exchange rate report for 2024. Central Bank of Nigeria; 2024. Available: https:\/\/www.cbn.gov.ng"},{"key":"2025080511200701000_10.8.e019270.14","unstructured":"World Bank . GDP per capita data for nigeria, 2024. World Bank; 2024. Available: https:\/\/data.worldbank.org [Accessed 27 Nov 2024]."},{"key":"2025080511200701000_10.8.e019270.15","unstructured":". Procurement Costs for 2024: Local Market Analysis and Supplier Quotes."},{"key":"2025080511200701000_10.8.e019270.16","unstructured":"U.S. Bureau of Labor Statistics . Consumer price index (cpi) database. U.S. Department of Labor; 2024. Available: https:\/\/www.bls.gov\/cpi\/ [Accessed 26 Nov 2024]."},{"key":"2025080511200701000_10.8.e019270.17","unstructured":"World Health Organization (WHO) . Guidelines for tuberculosis diagnosis and cost-effectiveness analysis. 2024. Available: https:\/\/www.who.int [Accessed 28 Nov 2024]."},{"key":"2025080511200701000_10.8.e019270.18","unstructured":"Stop TB Partnership . Cost-effectiveness of tb diagnostics: a global perspective. stop tb partnership. 2024. Available: https:\/\/www.stoptb.org [Accessed 28 Nov 2024]."},{"key":"2025080511200701000_10.8.e019270.19","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1367092","article-title":"Advancements in LAM-based diagnostic kit for tuberculosis detection: enhancing TB diagnosis in HIV-negative individuals","volume":"15","author":"Gao","year":"2024","journal-title":"Front Microbiol"},{"key":"2025080511200701000_10.8.e019270.20","unstructured":"Andrew B , Mark S , Karl C . Decision modelling for health economic evaluation. OUP Catalogue, Oxford University Press, 2006."},{"key":"2025080511200701000_10.8.e019270.21","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.mjafi.2018.06.003","article-title":"Tuberculosis diagnosis in resource limited settings","volume":"74","author":"Sen","year":"2018","journal-title":"Med J Armed Forces India"},{"key":"2025080511200701000_10.8.e019270.22","unstructured":"World Health Organization (WHO) . Diagnostic innovations for tuberculosis. Geneva: WHO; 2024. Available: https:\/\/www.who.int [Accessed 29 Nov 2024]."},{"key":"2025080511200701000_10.8.e019270.23","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/cid\/ciad501","article-title":"Cost-effectiveness of Low-complexity Screening Tests in Community-based Case-finding for Tuberculosis","volume":"78","author":"Br\u00fcmmer","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2025080511200701000_10.8.e019270.24","unstructured":"World Bank . Currency and economic stability reports for 2024. World Bank; 2024. Available: https:\/\/www.worldbank.org"},{"key":"2025080511200701000_10.8.e019270.25","unstructured":"World Health Organization (WHO) . Scaling up tb diagnostics for resource-limited settings. Geneva: World Health Organization; 2024. Available: https:\/\/iris.who.int\/bitstream\/handle\/10665\/366686\/9789240071353-eng.pdf"},{"key":"2025080511200701000_10.8.e019270.26","doi-asserted-by":"crossref","DOI":"10.11604\/pamj.2024.47.149.35719","article-title":"Predictors of tuberculosis treatment outcomes among people living with HIV in some States in Nigeria","volume":"47","author":"Olajide","year":"2024","journal-title":"Pan Afr Med J"},{"key":"2025080511200701000_10.8.e019270.27","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00257-2021","article-title":"Performance of Xpert MTB\/RIF Ultra for tuberculosis diagnosis in the context of passive and active case finding","volume":"58","author":"Saavedra","year":"2021","journal-title":"Eur Respir J"},{"key":"2025080511200701000_10.8.e019270.28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003113","article-title":"Diagnostic accuracy of a novel tuberculosis point-of-care urine lipoarabinomannan assay for people living with HIV: A meta-analysis of individual in- and outpatient data","volume":"17","author":"Broger","year":"2020","journal-title":"PLoS Med"},{"key":"2025080511200701000_10.8.e019270.29","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-019-3881-y","article-title":"Diagnostic accuracy of TB-LAMP for pulmonary tuberculosis: a systematic review and meta-analysis","volume":"19","author":"Shete","year":"2019","journal-title":"BMC Infect Dis"},{"key":"2025080511200701000_10.8.e019270.30","doi-asserted-by":"crossref","unstructured":"Dhana A , Hamada Y , Kengne AP , et al . Tuberculosis screening among ambulatory people living with HIV: a systematic review and individual participant data meta-analysis. Lancet Infect Dis 2022;507\u201318. doi:10.1016\/S1473-3099(23)00263-3","DOI":"10.1016\/S1473-3099(23)00263-3"},{"key":"2025080511200701000_10.8.e019270.31","unstructured":"Foundation for Innovative New Diagnostics (FIND) and World Health Organization (WHO) . Tuberculosis diagnostics pipeline report 2021. Geneva FIND and WHO; 2021. Available: https:\/\/www.finddx.org"},{"key":"2025080511200701000_10.8.e019270.32","unstructured":"Stop TB Partnership - TB-LAMP Test Announcement. Stop TB Partnership . TB-lamp test now available for $6 through global drug facility. Stop TB Partnership; 2024. Available: https:\/\/www.stoptb.org [Accessed 26 Nov 2024]."},{"key":"2025080511200701000_10.8.e019270.33","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-018-3636-1","article-title":"Cost of three models of care for drug-resistant tuberculosis patients in Nigeria","volume":"19","author":"Bada","year":"2019","journal-title":"BMC Infect Dis"}],"container-title":["BMJ Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgh-2025-019270","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T18:20:21Z","timestamp":1754418021000},"score":1,"resource":{"primary":{"URL":"https:\/\/gh.bmj.com\/lookup\/doi\/10.1136\/bmjgh-2025-019270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":33,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8,5]]},"published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10.1136\/bmjgh-2025-019270"],"URL":"https:\/\/doi.org\/10.1136\/bmjgh-2025-019270","relation":{},"ISSN":["2059-7908"],"issn-type":[{"value":"2059-7908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8]]}}}